| Symbol |
Name |
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ACAD8
|
acyl-CoA dehydrogenase family, member 8
|
|
ACKR3
|
atypical chemokine receptor 3
|
|
ADGRG2
|
adhesion G protein-coupled receptor G2
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADIPOR1
|
adiponectin receptor 1
|
|
ADIPOR2
|
adiponectin receptor 2
|
|
AFP
|
alpha-fetoprotein
|
|
AGTR1
|
angiotensin II receptor, type 1
|
|
AHR
|
aryl hydrocarbon receptor
|
|
AMH
|
anti-Mullerian hormone
|
|
ANGPT1
|
angiopoietin 1
|
|
ANGPT2
|
angiopoietin 2
|
|
ANGPTL8
|
angiopoietin like 8
|
|
ANO1
|
anoctamin 1, calcium activated chloride channel
|
|
ANXA1
|
annexin A1
|
|
ANXA5
|
annexin A5
|
|
AQP4
|
aquaporin 4
|
|
ARID1A
|
AT rich interactive domain 1A (SWI-like)
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BMI1
|
BMI1 proto-oncogene, polycomb ring finger
|
|
BMP2
|
bone morphogenetic protein 2
|
|
BMPR1A
|
bone morphogenetic protein receptor, type IA
|
|
BMPR1B
|
bone morphogenetic protein receptor, type IB
|
|
BMPR2
|
bone morphogenetic protein receptor, type II (serine/threonine kinase)
|
|
BRD2
|
bromodomain containing 2
|
|
CALCRL
|
calcitonin receptor-like
|
|
CALR
|
calreticulin
|
|
CCL14
|
chemokine (C-C motif) ligand 14
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL20
|
chemokine (C-C motif) ligand 20
|
|
CCL21
|
chemokine (C-C motif) ligand 21
|
|
CCL23
|
chemokine (C-C motif) ligand 23
|
|
CCL4
|
chemokine (C-C motif) ligand 4
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCM2
|
cerebral cavernous malformation 2
|
|
CCNA2
|
cyclin A2
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CCR6
|
chemokine (C-C motif) receptor 6
|
|
CCR7
|
chemokine (C-C motif) receptor 7
|
|
CD274
|
CD274 molecule
|
|
CD28
|
CD28 molecule
|
|
CD80
|
CD80 molecule
|
|
CD86
|
CD86 molecule
|
|
CERT1
|
ceramide transporter 1
|
|
CFP
|
complement factor properdin
|
|
CGA
|
glycoprotein hormones, alpha polypeptide
|
|
CGB
|
chorionic gonadotropin, beta polypeptide
|
|
CGB5
|
chorionic gonadotropin, beta polypeptide 5
|
|
CGB8
|
chorionic gonadotropin, beta polypeptide 8
|
|
CHDH
|
choline dehydrogenase
|
|
CMKLR1
|
chemerin chemokine-like receptor 1
|
|
COPS5
|
COP9 signalosome subunit 5
|
|
CORIN
|
corin, serine peptidase
|
|
COX2
|
|
|
CREBRF
|
CREB3 regulatory factor
|
|
CRH
|
corticotropin releasing hormone
|
|
CRISP3
|
cysteine-rich secretory protein 3
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CRTC1
|
CREB regulated transcription coactivator 1
|
|
CSDC2
|
cold shock domain containing C2, RNA binding
|
|
CSF3
|
colony stimulating factor 3 (granulocyte)
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTSE
|
cathepsin E
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL6
|
chemokine (C-X-C motif) ligand 6
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYP11A1
|
cytochrome P450, family 11, subfamily A, polypeptide 1
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
|
CYP26A1
|
cytochrome P450, family 26, subfamily A, polypeptide 1
|
|
DCN
|
decorin
|
|
DEDD
|
death effector domain containing
|
|
DEK
|
DEK proto-oncogene
|
|
DHFR
|
dihydrofolate reductase
|
|
DHRS11
|
dehydrogenase/reductase (SDR family) member 11
|
|
DKK1
|
dickkopf WNT signaling pathway inhibitor 1
|
|
DOCK1
|
dedicator of cytokinesis 1
|
|
DSG2
|
desmoglein 2
|
|
DST
|
dystonin
|
|
EBP
|
emopamil binding protein (sterol isomerase)
|
|
EGFR
|
epidermal growth factor receptor
|
|
ERBB4
|
erb-b2 receptor tyrosine kinase 4
|
|
ERN1
|
endoplasmic reticulum to nucleus signaling 1
|
|
ERVW-1
|
endogenous retrovirus group W, member 1
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
ETV4
|
ets variant 4
|
|
EXOC2
|
exocyst complex component 2
|
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
|
FAAH
|
fatty acid amide hydrolase
|
|
FABP4
|
fatty acid binding protein 4, adipocyte
|
|
FADS3
|
fatty acid desaturase 3
|
|
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a)
|
|
FCGR3B
|
Fc fragment of IgG, low affinity IIIb, receptor (CD16b)
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGF7
|
fibroblast growth factor 7
|
|
FGF9
|
fibroblast growth factor 9
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FGR
|
FGR proto-oncogene, Src family tyrosine kinase
|
|
FIGF
|
c-fos induced growth factor (vascular endothelial growth factor D)
|
|
FKBP4
|
FK506 binding protein 4, 59kDa
|
|
FOXO3
|
forkhead box O3
|
|
FOXP3
|
forkhead box P3
|
|
FST
|
follistatin
|
|
FTO
|
fat mass and obesity associated
|
|
FUT4
|
fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific)
|
|
FXR1
|
fragile X mental retardation, autosomal homolog 1
|
|
GADD45A
|
growth arrest and DNA-damage-inducible, alpha
|
|
GH1
|
growth hormone 1
|
|
GHRH
|
growth hormone releasing hormone
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GNB3
|
guanine nucleotide binding protein (G protein), beta polypeptide 3
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
HAVCR2
|
hepatitis A virus cellular receptor 2
|
|
HDAC2
|
histone deacetylase 2
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HIST3H3
|
histone cluster 3, H3
|
|
HLA-F
|
major histocompatibility complex, class I, F
|
|
HSD11B1
|
hydroxysteroid (11-beta) dehydrogenase 1
|
|
HSD11B2
|
hydroxysteroid (11-beta) dehydrogenase 2
|
|
HSD17B13
|
hydroxysteroid (17-beta) dehydrogenase 13
|
|
HSD17B7
|
hydroxysteroid (17-beta) dehydrogenase 7
|
|
HSD3B1
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1
|
|
HTRA3
|
HtrA serine peptidase 3
|
|
IFNA1
|
interferon, alpha 1
|
|
IFNA13
|
interferon, alpha 13
|
|
IFNG
|
interferon, gamma
|
|
IFNGR1
|
interferon gamma receptor 1
|
|
IFNGR2
|
interferon gamma receptor 2 (interferon gamma transducer 1)
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IL10
|
interleukin 10
|
|
IL1B
|
interleukin 1, beta
|
|
IL2
|
interleukin 2
|
|
IL24
|
interleukin 24
|
|
IL25
|
interleukin 25
|
|
IL33
|
interleukin 33
|
|
IL4
|
interleukin 4
|
|
IL4R
|
interleukin 4 receptor
|
|
IL6
|
interleukin 6
|
|
ILK
|
integrin-linked kinase
|
|
KDM5B
|
lysine (K)-specific demethylase 5B
|
|
KDR
|
kinase insert domain receptor
|
|
KISS1R
|
KISS1 receptor
|
|
KLF8
|
Kruppel-like factor 8
|
|
LASP1
|
LIM and SH3 protein 1
|
|
LEP
|
leptin
|
|
LGALS13
|
lectin, galactoside-binding, soluble, 13
|
|
LGALS14
|
lectin, galactoside-binding, soluble, 14
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LGALS9
|
lectin, galactoside-binding, soluble, 9
|
|
LIF
|
leukemia inhibitory factor
|
|
LIN28B
|
lin-28 homolog B (C. elegans)
|
|
LY96
|
lymphocyte antigen 96
|
|
MDC1
|
mediator of DNA-damage checkpoint 1
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MMEL1
|
membrane metallo-endopeptidase-like 1
|
|
MMP10
|
matrix metallopeptidase 10
|
|
MMP13
|
matrix metallopeptidase 13
|
|
MMP15
|
matrix metallopeptidase 15 (membrane-inserted)
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MMP7
|
matrix metallopeptidase 7
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MTHFD1L
|
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTR
|
5-methyltetrahydrofolate-homocysteine methyltransferase
|
|
MTRR
|
5-methyltetrahydrofolate-homocysteine methyltransferase reductase
|
|
MUC16
|
mucin 16, cell surface associated
|
|
MYDGF
|
myeloid-derived growth factor
|
|
NAMPT
|
nicotinamide phosphoribosyltransferase
|
|
NAT1
|
N-acetyltransferase 1 (arylamine N-acetyltransferase)
|
|
NCAM1
|
neural cell adhesion molecule 1
|
|
NCOA2
|
nuclear receptor coactivator 2
|
|
NDRG1
|
N-myc downstream regulated 1
|
|
NDRG4
|
NDRG family member 4
|
|
NME1
|
NME/NM23 nucleoside diphosphate kinase 1
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NR4A1
|
nuclear receptor subfamily 4, group A, member 1
|
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2
|
|
ODC1
|
ornithine decarboxylase 1
|
|
OSM
|
oncostatin M
|
|
OTC
|
ornithine carbamoyltransferase
|
|
OVGP1
|
oviductal glycoprotein 1, 120kDa
|
|
PAEP
|
progestagen-associated endometrial protein
|
|
PAG1
|
phosphoprotein membrane anchor with glycosphingolipid microdomains 1
|
|
PALD1
|
phosphatase domain containing, paladin 1
|
|
PALLD
|
palladin, cytoskeletal associated protein
|
|
PAPPA2
|
pappalysin 2
|
|
PARVB
|
parvin, beta
|
|
PCLAF
|
PCNA clamp associated factor
|
|
PCSK5
|
proprotein convertase subtilisin/kexin type 5
|
|
PDCD1
|
programmed cell death 1
|
|
PDCD10
|
programmed cell death 10
|
|
PDCD4
|
programmed cell death 4 (neoplastic transformation inhibitor)
|
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
|
PFKFB3
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3
|
|
PGF
|
placental growth factor
|
|
PGR
|
progesterone receptor
|
|
PIGF
|
phosphatidylinositol glycan anchor biosynthesis, class F
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CB
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
|
|
PIK3CD
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PIK3IP1
|
phosphoinositide-3-kinase interacting protein 1
|
|
PLXNB1
|
plexin B1
|
|
PML
|
promyelocytic leukemia
|
|
POMC
|
proopiomelanocortin
|
|
PPARA
|
peroxisome proliferator-activated receptor alpha
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PRDX1
|
peroxiredoxin 1
|
|
PRDX2
|
peroxiredoxin 2
|
|
PRKAR1A
|
protein kinase, cAMP-dependent, regulatory, type I, alpha
|
|
PRKAR2A
|
protein kinase, cAMP-dependent, regulatory, type II, alpha
|
|
PRKG2
|
protein kinase, cGMP-dependent, type II
|
|
PRL
|
prolactin
|
|
PROK1
|
prokineticin 1
|
|
PROKR1
|
prokineticin receptor 1
|
|
PROKR2
|
prokineticin receptor 2
|
|
PROM1
|
prominin 1
|
|
PRSS56
|
protease, serine, 56
|
|
PTGIR
|
prostaglandin I2 (prostacyclin) receptor (IP)
|
|
PTGIS
|
prostaglandin I2 (prostacyclin) synthase
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PXDN
|
peroxidasin
|
|
RAMP1
|
receptor (G protein-coupled) activity modifying protein 1
|
|
RARRES2
|
retinoic acid receptor responder (tazarotene induced) 2
|
|
RHD
|
Rh blood group, D antigen
|
|
S100A8
|
S100 calcium binding protein A8
|
|
S100A9
|
S100 calcium binding protein A9
|
|
SCAF1
|
SR-related CTD-associated factor 1
|
|
SDC4
|
syndecan 4
|
|
SEPP1
|
selenoprotein P, plasma, 1
|
|
SERPINB5
|
serpin peptidase inhibitor, clade B (ovalbumin), member 5
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SGK1
|
serum/glucocorticoid regulated kinase 1
|
|
SHBG
|
sex hormone-binding globulin
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
|
SLIT2
|
slit homolog 2 (Drosophila)
|
|
SPARCL1
|
SPARC-like 1 (hevin)
|
|
STX2
|
syntaxin 2
|
|
TDO2
|
tryptophan 2,3-dioxygenase
|
|
TG
|
thyroglobulin
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
THBS1
|
thrombospondin 1
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TLR4
|
toll-like receptor 4
|
|
TNF
|
tumor necrosis factor
|
|
TP53
|
tumor protein p53
|
|
TPO
|
thyroid peroxidase
|
|
TPPP3
|
tubulin polymerization-promoting protein family member 3
|
|
TTN
|
titin
|
|
TXNIP
|
thioredoxin interacting protein
|
|
USP7
|
ubiquitin specific peptidase 7 (herpes virus-associated)
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
WDR20
|
WD repeat domain 20
|
|
WNT5A
|
wingless-type MMTV integration site family, member 5A
|